131 related articles for article (PubMed ID: 9112757)
1. Determination of molecular associations of some hydrophobic and hydrophilic bile acids by infrared and Raman spectroscopy.
Lamcharfi E; Cohen-Solal C; Parquet M; Lutton C; Dupré J; Meyer C
Eur Biophys J; 1997; 25(4):285-91. PubMed ID: 9112757
[TBL] [Abstract][Full Text] [Related]
2. Aqueous solubility and acidity constants of cholic, deoxycholic, chenodeoxycholic, and ursodeoxycholic acids.
Moroi Y; Kitagawa M; Itoh H
J Lipid Res; 1992 Jan; 33(1):49-53. PubMed ID: 1552232
[TBL] [Abstract][Full Text] [Related]
3. Structure-retention correlation of isomeric bile acids in inclusion high-performance liquid chromatography with methyl beta-cyclodextrin.
Momose T; Yamaguchi Y; Iida T; Goto J; Nambara T
Lipids; 1998 Jan; 33(1):101-8. PubMed ID: 9470179
[TBL] [Abstract][Full Text] [Related]
4. 13C nuclear magnetic resonance data of bile acid derivatives.
Dias JR; Gao H; Kolehmainen E
Spectrochim Acta A Mol Biomol Spectrosc; 2000 Jan; 56A(1):53-77. PubMed ID: 10728856
[TBL] [Abstract][Full Text] [Related]
5. Heuman indices of hydrophobicity of bile acids and their comparison with a newly developed and conventional molecular descriptors.
Poša M
Biochimie; 2014 Feb; 97():28-38. PubMed ID: 24076126
[TBL] [Abstract][Full Text] [Related]
6. Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC.
Roda A; Minutello A; Angellotti MA; Fini A
J Lipid Res; 1990 Aug; 31(8):1433-43. PubMed ID: 2280184
[TBL] [Abstract][Full Text] [Related]
7. Chemical synthesis of 24-beta-D-galactopyranosides of bile acids: a new type of bile acid conjugates in human urine.
Kakiyama G; Sadakiyo S; Iida T; Mushiake K; Goto T; Mano N; Goto J; Nambara T
Chem Phys Lipids; 2005 Apr; 134(2):141-50. PubMed ID: 15784232
[TBL] [Abstract][Full Text] [Related]
8. 1H and 13C NMR characterization and stereochemical assignments of bile acids in aqueous media.
Ijare OB; Somashekar BS; Jadegoud Y; Nagana Gowda GA
Lipids; 2005 Oct; 40(10):1031-41. PubMed ID: 16382575
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of [3,4-(13)c(2)]-enriched bile salts as NMR probes of protein-ligand interactions.
Tochtrop GP; DeKoster GT; Cistola DP; Covey DF
J Org Chem; 2002 Sep; 67(19):6764-71. PubMed ID: 12227809
[TBL] [Abstract][Full Text] [Related]
10. Bile acid amidoalcohols: simple organogelators.
Valkonen A; Lahtinen M; Virtanen E; Kaikkonen S; Kolehmainen E
Biosens Bioelectron; 2004 Dec; 20(6):1233-41. PubMed ID: 15556372
[TBL] [Abstract][Full Text] [Related]
11. Chemometric and conformational approach to the analysis of the aggregation capabilities in a set of bile salts of the allo and normal series.
Poša M; Sebenji A
J Pharm Biomed Anal; 2016 Mar; 121():316-324. PubMed ID: 26746785
[TBL] [Abstract][Full Text] [Related]
12. The mutagenicity of bile acids using a fluctuation test.
Watabe J; Bernstein H
Mutat Res; 1985; 158(1-2):45-51. PubMed ID: 2995801
[TBL] [Abstract][Full Text] [Related]
13. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
Salen G; Tint GS; Eliav B; Deering N; Mosbach EH
J Clin Invest; 1974 Feb; 53(2):612-21. PubMed ID: 11344576
[TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance spectroscopy of bile acids. Development of two-dimensional NMR methods for the elucidation of proton resonance assignments for five common hydroxylated bile acids, and their parent bile acid, 5 beta-cholanoic acid.
Waterhous DV; Barnes S; Muccio DD
J Lipid Res; 1985 Sep; 26(9):1068-78. PubMed ID: 4067429
[TBL] [Abstract][Full Text] [Related]
15. The influence of NaCl on hydrophobicity of selected, pharmacologically active bile acids expressed with chromatographic retention index and critical micellar concentration.
Posa M; Pilipović A; Lalić M
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):336-43. PubMed ID: 20702073
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps.
Batta AK; Salen G; Holubec H; Brasitus TA; Alberts D; Earnest DL
Cancer Res; 1998 Apr; 58(8):1684-7. PubMed ID: 9563483
[TBL] [Abstract][Full Text] [Related]
17. Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification.
Aldini R; Roda A; Montagnani M; Cerrè C; Pellicciari R; Roda E
Steroids; 1996 Oct; 61(10):590-7. PubMed ID: 8910972
[TBL] [Abstract][Full Text] [Related]
18. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
Salen G; Verga D; Batta AK; Tint GS; Shefer S
Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum bile acids in normal human subjects following the adoption of a low-fat diet.
Martucci CP; Miller DG; Levine B; Tint GS; Fishman J
Ann N Y Acad Sci; 1995 Sep; 768():331-3. PubMed ID: 8526380
[No Abstract] [Full Text] [Related]
20. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
Batta AK; Salen G; Tint GS
Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
